Levothyroxine Sodium Tablet
Product Images NDC 51655-924

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

FDA Label Image

Label (51655 924 52 Master Bottle Label Approval Rev A 03 22)

Label (51655 924 52 Master Bottle Label Approval   Rev A 03 22)
Levothyroxine Sodium Tablets, USP 50 mcg (0.05mg), packaged in a container with 30 tablets. The recommended storage temperatures are between 25°C (77°F) and 30°C (86°F), with excursions permitted to 75°-30°C (59°-86°F). The tablets should be kept in their original container, protected from light and moisture, and kept out of reach of children. Each tablet contains Levothyroxine Sodium USP 50 mcg (0.05mg). The GTIN number for this product is 0351655924625, and it was repackaged by Northwind Pharmaceuticals in Indianapolis. This product has a Lot number of 0000000000, and the expiration date is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.